🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Sleeve Lobectomy for Lung Cancer in Minimally Invasive Surgical Techniques

Recruitingn/aAges 18 Years - anyAllSecond Affiliated Hospital, Zhejiang University, …
NCT06687408 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this multicenter observational study is to evaluate the long-term survival and perioperative outcomes of sleeve lobectomy in robotic-assisted thoracic surgery (RATS) for patients with central lung cancer when compared with video-assisted thoracic surgery (VATS) approach, both of which have been already applied to these patients in minimally invasive surgical techniques as part of their regular medical care recently. The main question it aims to answer is: Are RATS sleeve lobectomy associated with similar or even better long-term survival and perioperative outcomes for patients with central lung cancer when compared with the VATS approach?

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 years; * Clinically suspected lung cancer with a high likelihood of undergoing sleeve lobectomy; * Postoperative histopathological diagnosis confirms non-small cell lung cancer (NSCLC); * No history of malignancy within the past 5 years; * Signed informed consent agreeing to participate in this study. Exclusion Criteria: * Unable to undergo surgical resection due to surgical contraindications; * Postoperative pathology does not confirm non-small cell lung cancer (NSCLC), including but not limited to benign lesions, small cell lung cancer, metastatic tumors, or an insufficient or indeterminate histopathology report; * History of malignancy within the past 5 years; * Unable to obtain follow-up data; * Refusal to sign the informed consent or withdrawal of consent.
💊

What it tests

  • RATS Group
  • VATS group
📍

Where

3 sites
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, China
Sir Run Run Shaw Hospital, Medical College, Zhejiang University
Hangzhou, China
Shanghai Chest Hospital, Shanghai Jiao Tong University
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy